A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real Life
Journal of Clinical Medicine · 12.10.2024 · 13 (20) · 6079
DOI: 10.3390/jcm13206079 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.10.2024. Verfasst von Luigi Simone Aversa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Adult growth hormone deficiency (GHD) has been recognized since the late 1980s. The clinical manifestations of adult GHD are often nonspecific, and diagnosis relies on GH stimulation tests, which are intricate, costly, time-consuming, and may carry the risk of adverse effects. Diagnosis is further complicated by factors like age, sex, and BMI, which affect GH response during testing. Therefore, GH replacement therapy remains challenging, requiring careful individualized evaluation of risks and benefits. The aim of this review is to provide an update on diagnosing and treating adult GHD, addressing current limitations and challenges based on recent studies.
Methods
We conducted a comprehensive review of the literature regarding the diagnosis and management of adult GHD by searching PubMed and EMBASE. Only articles in English were included, and searches were conducted up to August 2024.
Results
A review of guidelines and literature up to 2024 highlights the significant heterogeneity in the data and reveals various protocols for managing GHD, covering both diagnostic and therapeutic approaches.
Conclusions
Despite diagnostic and treatment advances, managing adult GHD remains challenging due to variable presentation and the need for personalized GH therapy. Future efforts should aim to improve and standardize diagnostic and treatment protocols.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
ORCID-Profile: Luigi Simone Aversa, Daniela Cuboni, Silvia Grottoli, Ezio Ghigo, Valentina Gasco
Zitieren
APA
Aversa, L. S., Cuboni, D., Grottoli, S., Ghigo, E., & Gasco, V. (2024). A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real Life. Journal of Clinical Medicine, 13(20), 6079. https://doi.org/10.3390/jcm13206079
Vancouver
Aversa LS, Cuboni D, Grottoli S, Ghigo E, Gasco V. A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real Life. Journal of Clinical Medicine. 2024;13(20):6079. doi:10.3390/jcm13206079
BibTeX
@article{Aversa2024,
author = {Aversa, Luigi Simone and Cuboni, Daniela and Grottoli, Silvia and Ghigo, Ezio and Gasco, Valentina},
title = {A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real Life},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {20},
pages = {6079},
doi = {10.3390/jcm13206079}
}
EUVIMED